Lamivudine Therapy Exacerbates Bilirubinemia in Patients Underlying Severely Advanced Hepatitis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2234-2753
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Lamivudine Therapy Exacerbates Bilirubinemia in Patients Underlying Severely Advanced Hepatitis ; volume:33 ; number:4 ; day:1 ; month:10 ; year:2017 ; pages:343-350 ; date:10.2017
Toxicological research ; 33, Heft 4 (1.10.2017), 343-350, 10.2017
- Creator
-
Choi, Young Hee
Lee, Chang Ho
Ko, Myong Suk
Han, Hyun Joo
Kim, Sang Geon
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.5487/TR.2017.33.4.343
- URN
-
urn:nbn:de:101:1-2021090420350299749212
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Choi, Young Hee
- Lee, Chang Ho
- Ko, Myong Suk
- Han, Hyun Joo
- Kim, Sang Geon
- SpringerLink (Online service)
Other Objects (12)
Meta-analysis: Adefovir dipivoxil in combination with lamivudine in patients with lamivudine-resistant hepatitis B virus
Lamivudine therapy for chronic hepatitis B in children: a meta-analysis
Lamivudine plus adefovir is a good option for chronic hepatitis B patients with viral relapse after cessation of lamivudine treatment
Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis
Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis
Lamivudine sensitivity - a case report
Meta-analysis of the short-term effects of lamivudine treatment for severe chronic hepatitis B
Mutation Pattern of Lamivudine Resistance in Relation to Hepatitis B Genotypes : Abhängigkeit zwischen Lamivudin induziertem Resistenzmuster und Hepatitis B Genotyp
Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis
Depletion of RIPK1 in hepatocytes exacerbates liver damage in fulminant viral hepatitis
Immunstimulation bei Patienten mit chronischer Hepatitis B durch eine Kombination aus intradermaler Vakzine, Lamivudine und Interleukin-2
Cost-effectiveness analysis of different rescue therapies in patients with lamivudine-resistant chronic hepatitis B in China
Meta-analysis: Adefovir dipivoxil in combination with lamivudine in patients with lamivudine-resistant hepatitis B virus
Lamivudine therapy for chronic hepatitis B in children: a meta-analysis
Lamivudine plus adefovir is a good option for chronic hepatitis B patients with viral relapse after cessation of lamivudine treatment
Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis
Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis
Lamivudine sensitivity - a case report
Meta-analysis of the short-term effects of lamivudine treatment for severe chronic hepatitis B
Mutation Pattern of Lamivudine Resistance in Relation to Hepatitis B Genotypes : Abhängigkeit zwischen Lamivudin induziertem Resistenzmuster und Hepatitis B Genotyp
Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis
Depletion of RIPK1 in hepatocytes exacerbates liver damage in fulminant viral hepatitis
Immunstimulation bei Patienten mit chronischer Hepatitis B durch eine Kombination aus intradermaler Vakzine, Lamivudine und Interleukin-2
Cost-effectiveness analysis of different rescue therapies in patients with lamivudine-resistant chronic hepatitis B in China
Meta-analysis: Adefovir dipivoxil in combination with lamivudine in patients with lamivudine-resistant hepatitis B virus
Lamivudine therapy for chronic hepatitis B in children: a meta-analysis
Lamivudine plus adefovir is a good option for chronic hepatitis B patients with viral relapse after cessation of lamivudine treatment
Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis
Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis
Lamivudine sensitivity - a case report
Meta-analysis of the short-term effects of lamivudine treatment for severe chronic hepatitis B
Mutation Pattern of Lamivudine Resistance in Relation to Hepatitis B Genotypes : Abhängigkeit zwischen Lamivudin induziertem Resistenzmuster und Hepatitis B Genotyp
Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis
Depletion of RIPK1 in hepatocytes exacerbates liver damage in fulminant viral hepatitis
Immunstimulation bei Patienten mit chronischer Hepatitis B durch eine Kombination aus intradermaler Vakzine, Lamivudine und Interleukin-2